Completed NA INTERVENTIONAL 2-arm NCT01393301

Integrated Treatment for Smoking Cessation & Anxiety in People With HIV (Project Quit)

Sponsor: Massachusetts General Hospital

Conditions HIV Nicotine Dependence Symptoms of Anxiety

Interventions Control Integrated cognitive-behavioral therapy for smoking cessation and anxiety

Updated 8 times since 2017 Last updated: Apr 7, 2023 Started: Oct 31, 2011 Primary completion: May 31, 2015 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01393301, this NA trial focuses on HIV and Nicotine Dependence and remains completed. Sponsored by Massachusetts General Hospital, it has been updated 8 times since 2011, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Jun 2023 [monthly]

Completed NA
Apr 2019 — Jan 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Apr 2019 [monthly]

Completed NA
May 2017 — Jun 2018 [monthly]

Completed NA

Phase: PHASE1 → NA
Jan 2017 — May 2017 [monthly]

Completed PHASE1

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital
National Institute on Drug Abuse (NIDA)
Southern Methodist University
University of Houston

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States